- Programs & Services
Member out-of-pocket costs declined in 2017, and nearly nine out of 10 members spent less than $300 on their prescriptions over the course of the year. Only a small percentage of members paid over $1,000 a year. Many of these high-cost members had high deductible health plans or used specialty medications.
Prescription affordability helped plan members adhere to their prescribed therapies. Utilization grew by 1.7 percent, and the number of optimally adherent members increased in key categories such as hypertension and diabetes. Price growth of 0.2 percent combined with utilization growth of 1.7 percent resulted in an overall prescription trend of 1.9 percent for commercial clients. Overall trend was the lowest in five years, while adherence levels were the highest in seven years.
View more 2018 Forum highlights here.
Controlling costs is most payors’ primary concern. Our market-leading solutions help clients get ahead of trend drivers and achieve lowest net cost.
A comprehensive formulary strategy is foundational to mitigating the impact of escalating drug prices, and the introduction of new high-cost therapies.
Adherence results may vary based upon a variety of factors such as plan design, demographics and programs adopted by the plan. Client-specific modeling available upon request.
©2018 CVS Health and/or one of its affiliates: Confidential and Proprietary. Do not copy or distribute without written permission.